153 related articles for article (PubMed ID: 17768599)
1. Renal cell carcinoma bone metastasis--elucidating the molecular targets.
Weber K; Doucet M; Kominsky S
Cancer Metastasis Rev; 2007 Dec; 26(3-4):691-704. PubMed ID: 17768599
[TBL] [Abstract][Full Text] [Related]
2. Blockade of epidermal growth factor receptor signaling leads to inhibition of renal cell carcinoma growth in the bone of nude mice.
Weber KL; Doucet M; Price JE; Baker C; Kim SJ; Fidler IJ
Cancer Res; 2003 Jun; 63(11):2940-7. PubMed ID: 12782601
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta promotes the establishment of renal cell carcinoma bone metastasis.
Kominsky SL; Doucet M; Brady K; Weber KL
J Bone Miner Res; 2007 Jan; 22(1):37-44. PubMed ID: 17032147
[TBL] [Abstract][Full Text] [Related]
4. Renal cell carcinoma bone metastasis: epidermal growth factor receptor targeting.
Weber KL; Doucet M; Price JE
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S86-94. PubMed ID: 14600596
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a renal cell carcinoma cell line derived from a human bone metastasis and establishment of an experimental nude mouse model.
Weber KL; Pathak S; Multani AS; Price JE
J Urol; 2002 Aug; 168(2):774-9. PubMed ID: 12131367
[TBL] [Abstract][Full Text] [Related]
6. [Interleukin-6 and bone metastasis of renal cancer: molecular bases and therapeutic implications].
Paule B
Prog Urol; 2001 Apr; 11(2):368-75. PubMed ID: 11400511
[TBL] [Abstract][Full Text] [Related]
7. Macrophage inflammatory protein-1 delta: a novel osteoclast stimulating factor secreted by renal cell carcinoma bone metastasis.
Kominsky SL; Abdelmagid SM; Doucet M; Brady K; Weber KL
Cancer Res; 2008 Mar; 68(5):1261-6. PubMed ID: 18316587
[TBL] [Abstract][Full Text] [Related]
8. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
9. EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer.
Badalian G; Derecskei K; Szendroi A; Szendroi M; Tímár J
Anticancer Res; 2007; 27(2):889-94. PubMed ID: 17465216
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of MAPK kinase signaling pathways suppressed renal cell carcinoma growth and angiogenesis in vivo.
Huang D; Ding Y; Luo WM; Bender S; Qian CN; Kort E; Zhang ZF; VandenBeldt K; Duesbery NS; Resau JH; Teh BT
Cancer Res; 2008 Jan; 68(1):81-8. PubMed ID: 18172299
[TBL] [Abstract][Full Text] [Related]
12. Bone Metastasis from Renal Cell Carcinoma.
Chen SC; Kuo PL
Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27338367
[TBL] [Abstract][Full Text] [Related]
13. Sperm-associated antigen 9 is associated with tumor growth, migration, and invasion in renal cell carcinoma.
Garg M; Kanojia D; Khosla A; Dudha N; Sati S; Chaurasiya D; Jagadish N; Seth A; Kumar R; Gupta S; Gupta A; Lohiya NK; Suri A
Cancer Res; 2008 Oct; 68(20):8240-8. PubMed ID: 18922895
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
Clines GA; Guise TA
Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
[TBL] [Abstract][Full Text] [Related]
15. [TGF-beta signaling during bone metastasis of breast cancer and in-vivo imaging].
Imamura T; Hanyu A
Clin Calcium; 2008 Apr; 18(4):460-5. PubMed ID: 18379027
[TBL] [Abstract][Full Text] [Related]
16. A case of bone, lung, pleural and liver metastases from renal cell carcinoma which responded remarkably well to zoledronic acid monotherapy.
Miwa S; Mizokami A; Konaka H; Izumi K; Nohara T; Namiki M
Jpn J Clin Oncol; 2009 Nov; 39(11):745-50. PubMed ID: 19808839
[TBL] [Abstract][Full Text] [Related]
17. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
18. Local effects of malignancy on bone.
Brown SA; Clines GA; Guise TA
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):436-41. PubMed ID: 17982348
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone.
Sone S; Yano S
Cancer Metastasis Rev; 2007 Dec; 26(3-4):685-9. PubMed ID: 17786536
[TBL] [Abstract][Full Text] [Related]
20. Characterization of primary renal carcinoma cultures.
Sievers E; Dreimuller P; Haferkamp A; Schmidt-Wolf IG; Buchler MW; Schmidt J; Marten A
Urol Int; 2007; 79(3):235-43. PubMed ID: 17940356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
